KAUFMAN, MICHAEL D.,CALDWELL, TIMOTHY MALCOLM,FLYNN, DANIEL L.,PATT, WILLIAM C.,SAMARAKOON, THIWANKA,VOGETI, LAKSHMINARAYANA,YATES, KAREN M.
申请号：
SG11201508532V
公开号：
SG11201508532VA
申请日:
2014.03.14
申请国别(地区):
SG
年份:
2015
代理人:
摘要：
Described are compounds of Formula I which find utility in the treatment of cancer, autoimmune diseases and metabolic bone disorders through inhibition of c-FMS (CSF-1R), c-KIT, and/or PDGFR kinases. These compounds also find utility in the treatment of other mammalian diseases mediated by c-FMS, c-KIT, or PDGFR kinases.
